Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy : Results of a comparative performance analysis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:106 |
|---|---|
| Enthalten in: |
European journal of haematology - 106(2021), 3 vom: 16. März, Seite 425-427 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Molica, Stefano [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
1X70OSD4VX |
|---|
| Anmerkungen: |
Date Completed 29.07.2021 Date Revised 29.07.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ejh.13548 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317577360 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317577360 | ||
| 003 | DE-627 | ||
| 005 | 20231225163546.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ejh.13548 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1058.xml |
| 035 | |a (DE-627)NLM317577360 | ||
| 035 | |a (NLM)33190324 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Molica, Stefano |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy |b Results of a comparative performance analysis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.07.2021 | ||
| 500 | |a Date Revised 29.07.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a CLL | |
| 650 | 4 | |a ibrutinib | |
| 650 | 4 | |a performance analysis | |
| 650 | 4 | |a prognostic models | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Piperidines |2 NLM | |
| 650 | 7 | |a Protein Kinase Inhibitors |2 NLM | |
| 650 | 7 | |a ibrutinib |2 NLM | |
| 650 | 7 | |a 1X70OSD4VX |2 NLM | |
| 650 | 7 | |a Adenine |2 NLM | |
| 650 | 7 | |a JAC85A2161 |2 NLM | |
| 700 | 1 | |a Baumann, Tycho |e verfasserin |4 aut | |
| 700 | 1 | |a Giannarelli, Diana |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of haematology |d 1990 |g 106(2021), 3 vom: 16. März, Seite 425-427 |w (DE-627)NLM01261727X |x 1600-0609 |7 nnns |
| 773 | 1 | 8 | |g volume:106 |g year:2021 |g number:3 |g day:16 |g month:03 |g pages:425-427 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ejh.13548 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 106 |j 2021 |e 3 |b 16 |c 03 |h 425-427 | ||